Eiger Biopharmaceuticals Inc buy Reibach111
Start price
23.07.17
/
50%
€8.79
Target price
11.01.18
€13.53
Performance (%)
53.85%
End price
11.01.18
€13.53
Summary
This prediction ended on 11.01.18 with a price of €13.53. The BUY prediction by Reibach111 for Eiger Biopharmaceuticals Inc saw massive gains of 53.85%. Reibach111 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by Reibach111 for this prediction
In the thread Eiger Biopharmaceuticals Inc diskutieren
Reibach111 stimmt dem Crowdsentiment von 'Buy' zu
Reibach111 stimmt am 23.07.2017 dem Buy-Crowdsentiment mit dem Kursziel 13.3$ zu.
(Zielkurs erreicht)


